Clinical psychopharmacology in China: The last decade
Clinical psychopharmacological research has focused on several aspects in the last decade in China. First, attention was paid to new drug trials, mainly on newly developed or imported antidepressants or antipsychotics. More and more newly developed antidepressants like SSRI, fluoxetine, paroxetine, sertraline, and citalopram are now available or under clinical observation. Second, studies on the relationship between blood level and clinical response of antidepressants, amitriptyline, or antipsychotics, haloperidol and clozapine were undertaken. Results on amitriptyline showed that the clinical antidepressive effect of the drug was correlated linearly to the parent compound, amitriptyline, and curvilinearly to the hydroxylated metabolite, 10‐hydroxynortryptyline. It was found that the plasma level of haloperidol correlated curvilinearly to the clinical antipsychotic effect on schizophrenics with a therapeutic window ranging between 4.2 and 20 ng/mL. Third, pharmacokinetic studies on antidepressants, amitriptyline, imipramine, and maprotiline were undertaken. The results showed longer clearance rate and/or t1/2 in Chinese literature than those reported in Western literature.
1996 yılında Human Psychopharmacology: Clinical and Experimental dergisinde yayınlandı.
2016 yılında yayınlandı.
2008 yılında Ethics & Behavior dergisinde yayınlandı.
2004 yılında Pediatrics International dergisinde yayınlandı.
2002 yılında Journal of Nursing Scholarship dergisinde yayınlandı.
2020 yılında Haemophilia dergisinde yayınlandı.
2001 yılında Journal of Child Psychology and Psychiatry dergisinde yayınlandı.
2018 yılında Nordic Journal of Psychiatry dergisinde yayınlandı.
1992 yılında Governance dergisinde yayınlandı.